For immediate release 20 June 2006 BioProgress to acquire Segix Farma S.R.L. Cambridge, UK, 20 June 2006 - The Board of BioProgress plc ("BioProgress" or the "Company") (AIM: BPRG; NASDAQ: BPRG), the ...

FOR IMMEDIATE RELEASE 15 August 2006 Appointment and resignation of directors at BioProgress Cambridge, UK, 15 August 2006 - BioProgress plc ("BioProgress" or the "Company") (AIM: BPRG; NASDAQ: BPRG), ...

ADDISON, Texas, Feb. 8 /PRNewswire-FirstCall/ -- ULURU Inc. (OTC Bulletin Board: ULUR) today announced that it has signed a strategic partnership with BioProgress plc ...

The expression "a bitter pill to swallow" could soon become obsolete if patients warm to a new type of medicine - a postage-stamp sized film that dissolves on your tongue. Graham Hind, the chief ...

Bioprogress is finally living up to its name. But the shares are up 42 per cent since we rated them good value at the time of the interims in October so, on a forward PE ratio of 25, it's all in the ...

BioProgress will make its first foray into China, having appointed AXM Pharma as the distributor for its supplements that use dissolve-in-the-mouth-film technology, in what it hopes to be a lucrative ...

BioProgress and FMC have agreed to restructure their licensing partnership to more accurately reflect the intended market strategy for the NRobe technology and to accelerate its commercialization.

SAN FRANCISCO (MarketWatch) -- Shares of the U.K.'s BioProgress Plc surged Thursday, bouncing back from its earnings warning in the previous session and making it the biggest gainer among U.S.-listed ...

Graham Hind, chief executive of Bioprogress - the maker of dissolve-in-the-mouth breath fresheners and drug coatings - has resigned following last month's shock profit warning. Meanwhile, ...

BioProgress is well positioned to end the year for the first time in its history trading profitably at an EBITDA level." Application has been made to FTSE for BioProgress to be re-classified from ...

DALLAS, May 4 /PRNewswire-FirstCall/ -- ULURU Inc. (OTC Bulletin Board: ULURE) ("ULURU") today announced that it has signed a joint strategic development agreement ...

LONDON, Oct 26 (Reuters) - British pharmaceutical and medical devices company BioProgress Plc said it was in advanced talks to acquire U.S. assets and was also considering a cash placing. The group, ...